Donepezil use in the treatment of dementia associated with Down syndrome.
Cipriani
Giovanna
G
Bianchetti
Angelo
A
Trabucchi
Marco
M
D000328:Adult; D002800:Cholinesterase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology*; D000077265:Donepezil; D004314:Down Syndrome / Q000150:complications*; D005260:Female; D006801:Humans; D007189:Indans / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010880:Piperidines / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D012107:Research Design; D018401:Sample Size
D002800:Cholinesterase Inhibitors; D007189:Indans; D010880:Piperidines; D000077265:Donepezil